BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29882587)

  • 1. A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma.
    McKay P; Leach M; Jackson B; Robinson S; Rule S
    Br J Haematol; 2018 Jul; 182(1):63-70. PubMed ID: 29882587
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.
    Kiel MJ; Smith LB
    Arch Pathol Lab Med; 2012 Aug; 136(8):871-5. PubMed ID: 22849733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the real risk of central nervous system involvement in mantle cell lymphoma?
    Gill S; Seymour JF
    Leuk Lymphoma; 2008 Dec; 49(12):2237-9. PubMed ID: 19052969
    [No Abstract]   [Full Text] [Related]  

  • 4. Refining the predictors of risk for central nervous system involvement in patients with mantle cell lymphoma.
    Cheah CY; Seymour JF
    Leuk Lymphoma; 2013 Sep; 54(9):1859-61. PubMed ID: 23432685
    [No Abstract]   [Full Text] [Related]  

  • 5. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
    Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
    [No Abstract]   [Full Text] [Related]  

  • 6. Central nervous system prophylaxis in mantle cell lymphoma.
    Gatt ME; Grisaro S
    Blood; 2009 Dec; 114(26):5402-3; author reply 5403-4. PubMed ID: 20018927
    [No Abstract]   [Full Text] [Related]  

  • 7. Mantle cell lymphoma: primary oral presentation.
    Ainscough S; Power AM; Brown AN
    Ann R Coll Surg Engl; 2017 Jan; 99(1):e13-e14. PubMed ID: 27551901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS involvement at diagnosis in mantle cell lymphoma with atypical MRI features.
    Faivre G; Lagarde J; Choquet S; Maillart E; Lubetzki C
    J Neurol; 2014 May; 261(5):1018-20. PubMed ID: 24609970
    [No Abstract]   [Full Text] [Related]  

  • 9. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
    Andhavarapu S; Crozier JA; Jiang L; Sher T
    Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and staging in gastrointestinal lymphoma.
    Boot H
    Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):3-12. PubMed ID: 20206103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
    Karam M; Ata A; Irish K; Feustel PJ; Mottaghy FM; Stroobants SG; Verhoef GE; Chundru S; Douglas-Nikitin V; Oliver Wong CY; Brepoels LM
    Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pitfalls and update in haematopathology. Case 3. Mantle cell lymphoma, aggressive variant, pleomorphic].
    Molina T
    Ann Pathol; 2012 Oct; 32(5):341-5. PubMed ID: 23141942
    [No Abstract]   [Full Text] [Related]  

  • 13. Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?
    Romancik JT; Cohen JB
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):849-859. PubMed ID: 32861282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
    Cox MC; Mannino G; Lionetto L; Naso V; Simmaco M; Spiriti MA
    Am J Hematol; 2011 Nov; 86(11):957. PubMed ID: 21990093
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary central nervous system involvement in cyclin D1-negative mantle cell lymphoma.
    Dierickx D; Wlodarska I; Vanhentenrijk V; De Wolf-Peeters C; Devos T; Delforge M; Janssens A; Maertens J; Thomas J; Verhoef G
    Leuk Lymphoma; 2008 Dec; 49(12):2365-6. PubMed ID: 19052986
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report of mantle cell lymphoma manifesting as a foot lesion.
    Samarghandi A; Ahuja S; Gupta S; Fulger I; Katava G; Fang Y
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26797933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma: conjunctival mass in a female patient.
    Zhang X; Gordon KB; Zaldivar RA; Rajjoub LZ
    Can J Ophthalmol; 2018 Jun; 53(3):e109-e111. PubMed ID: 29784172
    [No Abstract]   [Full Text] [Related]  

  • 18. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
    Fey MF
    Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ mantle cell lymphoma in the nasopharynx.
    Koletsa T; Markou K; Ouzounidou S; Tsiompanou F; Karkavelas G; Kostopoulos I
    Head Neck; 2013 Nov; 35(11):E333-7. PubMed ID: 23280758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
    Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
    Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.